![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 38/26 | |
A61K 39/395 | |||
A61P 3/10 | |||
C07K 16/24 | |||
A61K 39/00 |
(11) | Patento numeris | 3139948 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 15720982.6 |
Europos patento paraiškos padavimo data | 2015-05-05 | |
(97) | Europos patento paraiškos paskelbimo data | 2017-03-15 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2020-03-04 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/EP2015/059811 |
Data | 2015-05-05 |
(87) | Numeris | WO 2015/169789 |
Data | 2015-11-12 |
(30) | Numeris | Data | Šalis |
201461989841 P | 2014-05-07 | US | |
14169596 | 2014-05-23 | EP | |
14189732 | 2014-10-21 | EP |
(72) |
COPPIETERS, Ken, DK
VON HERRATH, Matthias, US
BOURSALIAN, Tamar, US
|
(73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
(54) | TREATMENT OF DIABETES TYPE 1 USING GLP-1 AND ANTI-IL-21 |
TREATMENT OF DIABETES TYPE 1 USING GLP-1 AND ANTI-IL-21 |